Serious infectious events and ibuprofen administration in pediatrics: a narrative review in the era of COVID-19 pandemic.
Lucia QuagliettaMassimo MartinelliAnnamaria StaianoPublished in: Italian journal of pediatrics (2021)
Ibuprofen is associated with severe necrotizing soft tissue infections (NSTI) during chickenpox course. Pre-hospital use of ibuprofen seems to increase the risk of complicated pneumonia in children. Conflicting data have been published in septic children, while ibuprofen in the setting of Cystic Fibrosis (CF) exacerbations is safe and efficacious. No data is yet available for ibuprofen use during COVID-19 course. Ibuprofen should not be recommended for chickenpox management. Due to possible higher risks of complicated pneumonia, we suggest caution on its use in children with respiratory symptoms. While it remains unclear whether ibuprofen may have harmful effects during systemic bacterial infection, its administration is recommended in CF course. Despite the lack of data, it is seems cautious to prefer the use of paracetamol during COVID-19 acute respiratory distress syndrome in children.
Keyphrases
- cystic fibrosis
- acute respiratory distress syndrome
- young adults
- postoperative pain
- electronic health record
- pseudomonas aeruginosa
- healthcare
- soft tissue
- extracorporeal membrane oxygenation
- acute kidney injury
- lung function
- intensive care unit
- machine learning
- risk assessment
- human health
- sleep quality
- respiratory tract